情報源 > 更に詳しい情報[014]
参考文献

(1) Stanisstreet M, Herbert LC, Pharoah POD. Effects of thyroid antagonists on rat embryos cultured in vitro. Teratology 1990; 41: 721-9.
(2) Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol 1984; 20: 695-700.
(3) Stanisstreet M, Pharoah POD, Herbert LC. Culture of rat embryos in sera from human hyperthyroid subjects. Med Sci Res 1988; 16: 1105-6.
(4) Harakawa S, Akazawa S, Akazawa M, et al. Changes of serum thyroid hormone levels induce malformations on early embryogenesis in rats. Acta Endocrinol (Copenh) 1989; 121: 739-43.
(5) Sparre LS. Maternal free thyroxine and thyroxine-binding globulin during pregnancy ending in congenital malformations in the offspring. Gynecol Obstet Invest 1989; 27: 19-21.
(6) Glinoer D, Lemone M. Goiter and pregnancy: A new insight into and old problem. Thyroid 1992; 2: 65-70.
(7) Gardner DF, Cruikshank DP, Hays PM, et al. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of matemal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 1986; 62: 217-20.
(8) Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986; 315: 24-8.
(9) Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997; 82: 3633-6.
(10) Dussault JH. Neonatal screening for congenital hypothyToidism. Clin Lab Med 1993; 13: 645-52.
(11) Delange F. Neonatal screening for congenital hypothyroidism: results and perspectives. Horrn Res 1997; 48: 51-61.
(12) McCaroll AM, Hutchinson M, McAuley R, et al. Long terrn assessment of children exposed in utero to carbimazole. Arch Dis Child 1976; 51: 532-6.
(13) Burrow GN, Klatskin EH, Genel M. Intellectual development in children whose mothers received propylt, hiouracil during pregnancy. Yale J Bio] Med 1978; 51: 151-6.
(14) Messer PM, Hauffa BP, Olbricht T, et al. Antithyroid drug treatment of Graves' disease in pregnancy: Iong-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol (Copenh) 1990; 123: 311-6.
(15) Eisenstein Z, Weiss M, Katz Y, et al. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992; 151: 558-9.
(16) Refetoff S, Ochi Y, Selenkow HA, et aL Neonat.al hypothyroidism and goiter in one infant of each of two sets of twins due to meternal therapy with antithyroid drugs. J Pediatr 1974; 85: 240-4.
(17) Robinson PL, O'Mullane NH, Aldernam B. Pr'e_na. tal t, rea.tment of fetal t.hyrotoxicosis. BMJ 1979; 1: 383-4.
(18) Cove DH, Johnston P. Fetal hyperthyroidism. Experience of treatment in four siblings. Lancet 1985; 1: 430-2.
(19) Momotani N, Hisaoka T, Noh J, et al. Effects of io. dine on thyroid status of fetus versus mot,her in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab 1992; 75: 738-44.

もどる